Carina Törn

4.0k total citations
64 papers, 1.9k citations indexed

About

Carina Törn is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Carina Törn has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Genetics, 51 papers in Surgery and 47 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Carina Törn's work include Diabetes and associated disorders (60 papers), Pancreatic function and diabetes (51 papers) and Diabetes Management and Research (43 papers). Carina Törn is often cited by papers focused on Diabetes and associated disorders (60 papers), Pancreatic function and diabetes (51 papers) and Diabetes Management and Research (43 papers). Carina Törn collaborates with scholars based in Sweden, United States and Germany. Carina Törn's co-authors include Mona Landin‐Olsson, Åke Lernmark, Ezio Bonifacio, Michael Schlosser, P.W. Mueller, Christer Petersson, Maria Thunander, P. J. Bingley, P. J. Bingley and Christiane S. Hampe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Carina Törn

63 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carina Törn Sweden 22 1.5k 1.2k 1.2k 200 132 64 1.9k
Eva Örtqvist Sweden 22 1.4k 0.9× 1.0k 0.8× 1.1k 0.9× 350 1.8× 154 1.2× 50 2.0k
K. Savola Finland 20 2.0k 1.3× 1.4k 1.1× 1.4k 1.2× 303 1.5× 124 0.9× 34 2.3k
Lisa K. Gilliam United States 16 888 0.6× 951 0.8× 828 0.7× 105 0.5× 183 1.4× 47 1.5k
Roshanak Monzavi United States 13 955 0.6× 1.0k 0.8× 791 0.7× 227 1.1× 125 0.9× 16 1.6k
Pierre Lecomte France 18 410 0.3× 770 0.6× 571 0.5× 90 0.5× 233 1.8× 26 1.3k
Maria Faresjö Sweden 16 609 0.4× 382 0.3× 416 0.4× 331 1.7× 66 0.5× 47 997
Piotr Fichna Poland 17 336 0.2× 352 0.3× 186 0.2× 168 0.8× 246 1.9× 71 1.0k
Claudia Giavoli Italy 23 236 0.2× 1.1k 0.9× 285 0.2× 28 0.1× 189 1.4× 85 1.5k
Sara Pagani Italy 20 240 0.2× 350 0.3× 111 0.1× 233 1.2× 180 1.4× 69 1.1k
K. O. NILSSON Sweden 14 387 0.3× 359 0.3× 229 0.2× 42 0.2× 181 1.4× 31 766

Countries citing papers authored by Carina Törn

Since Specialization
Citations

This map shows the geographic impact of Carina Törn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carina Törn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carina Törn more than expected).

Fields of papers citing papers by Carina Törn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carina Törn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carina Törn. The network helps show where Carina Törn may publish in the future.

Co-authorship network of co-authors of Carina Törn

This figure shows the co-authorship network connecting the top 25 collaborators of Carina Törn. A scholar is included among the top collaborators of Carina Törn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carina Törn. Carina Törn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salami, Falastin, Roy Tamura, Åke Lernmark, et al.. (2022). HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children. Pediatric Diabetes. 23(8). 1586–1593. 12 indexed citations
2.
Törn, Carina, Fariba Vaziri‐Sani, Anita Ramelius, et al.. (2022). Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden. Acta Diabetologica. 59(6). 773–781. 4 indexed citations
3.
Sharma, Ashok, Xiang Liu, David Hadley, et al.. (2018). Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort. Journal of Autoimmunity. 89. 90–100. 44 indexed citations
4.
Lynch, Kristian, Hye‐Seung Lee, Carina Törn, et al.. (2017). Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies. Journal of Autoimmunity. 86. 93–103. 18 indexed citations
5.
Lind, A. R., Eva Freyhult, Anita Ramelius, et al.. (2017). Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls. Viral Immunology. 30(8). 590–600. 5 indexed citations
6.
Friedman, Mikaela, Ping Ren, Carina Törn, et al.. (2015). Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome. Scientific Reports. 5(1). 11196–11196. 4 indexed citations
7.
8.
Jensen, Richard A., Elisabet Agardh, Åke Lernmark, et al.. (2011). HLA Genes, Islet Autoantibodies and Residual C-Peptide at the Clinical Onset of Type 1 Diabetes Mellitus and the Risk of Retinopathy 15 Years Later. PLoS ONE. 6(3). e17569–e17569. 28 indexed citations
9.
Törn, Carina, Young Ho Lee, Helena Elding Larsson, et al.. (2011). Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics. Journal of Perinatology. 31(12). 764–769. 7 indexed citations
10.
Johansson, Jesper, et al.. (2010). C-peptide in dried blood spots. Scandinavian Journal of Clinical and Laboratory Investigation. 70(6). 404–409. 10 indexed citations
11.
Schlosser, Michael, et al.. (2010). Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia. 53(12). 2611–2620. 132 indexed citations
12.
Vaziri‐Sani, Fariba, Shilpa Oak, Jared Radtke, et al.. (2010). ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity. 43(8). 598–606. 71 indexed citations
13.
Oak, Shilpa, Jared Radtke, Mona Landin‐Olsson, et al.. (2009). Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies. Journal of Immunological Methods. 351(1-2). 55–61. 5 indexed citations
14.
Oak, Shilpa, Lisa K. Gilliam, Mona Landin‐Olsson, et al.. (2008). The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proceedings of the National Academy of Sciences. 105(14). 5471–5476. 58 indexed citations
15.
Thunander, Maria, et al.. (2008). Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Research and Clinical Practice. 82(2). 247–255. 152 indexed citations
16.
Törn, Carina, Magnus Hillman, Carani B. Sanjeevi, & Mona Landin‐Olsson. (2006). Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus—a study in 609 Swedish subjects. Human Immunology. 67(7). 527–534. 10 indexed citations
17.
Schölin, Anna, Carina Törn, L. Nyström, et al.. (2004). Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes. Diabetic Medicine. 21(5). 447–455. 32 indexed citations
18.
19.
Månsson, Lisa, Carina Törn, & Mona Landin‐Olsson. (2001). Islet Cell Antibodies Represent Autoimmune Response Against Several Antigens. Journal of Diabetes Research. 2(2). 85–90. 15 indexed citations
20.
Bekris, Lynn M., Mona Landin‐Olsson, Carina Törn, et al.. (2000). Newly Diagnosed Latent Autoimmune Diabetes in Adults (LADA) is Associated with Low Level Glutamate Decarboxylase (GAD65) and IA-2 Autoantibodies. Hormone and Metabolic Research. 32(4). 133–138. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Örtqvist Breakdown of academic impact, for papers by K. Savola Breakdown of academic impact, for papers by Lisa K. Gilliam Breakdown of academic impact, for papers by Roshanak Monzavi Breakdown of academic impact, for papers by Pierre Lecomte Breakdown of academic impact, for papers by Maria Faresjö Breakdown of academic impact, for papers by Piotr Fichna Breakdown of academic impact, for papers by Claudia Giavoli Breakdown of academic impact, for papers by Sara Pagani Breakdown of academic impact, for papers by K. O. NILSSON
Rankless by CCL
2026